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INTRODUCTION:

The interrelationship of the thyroid gland and the cardiovascularsystem has been known since the early nineteenth century.

Hyperthyroi¬

dism, hy increasing oxygen consumption, can cause an almost concomitant
rise in cardiac output.

The arterial pulse pressure in hyperthyroidism

is increased because of an elevation of systolic pressure and a decrease
in peripheral resistance.
Interest in the relationship between the thyroid and hypertension,
therefore, was natural following the description by Goldblatt _et al
(193*0 of a mechanism for the production of persistent elevation of
systolic blood pressure by means of renal ischemia in dogs,
l) Hypertensive Studies in Dogs:
Page and Sweet (1937)? confirmed by Braun-Menendez (1952), showed
that dessicated thyroid (0.8 Grams) raised moderately the pressure of
hypertensive dogs whose pressure had previously been reduced by hypophysectomy.

Glenn and Lasher (1938)? however, using the Goldblatt

clamp, found that thyroidectomy caused no significant fall in blood
pressure and that the application of the clamp after thyroidectomy was
followed by a well sustained rise in the dogs* blood pressure.
cholesterol was used as an index of severity of myxedema.

Blood

These findings

were confirmed by Katz et al (1939)*
Page and Sweet (1937) bad postulated that the responsiveness of
blood vessels to chemical stimuli from the kidney was secondary to an
increase or decrease of thyroid or adrenal secretions.

Testing the effect

of the athyroid state on vascular reactivity and arterial pressure in
renal hypertensive dogs. Page and McCubbin (1952) showed that vascularresponsiveness to epinephrine, norepinephrine, renin and angiotensin was
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reduced -with suppression of thyroid function in normotensive dogs.

The

possibility that suppression of thyroid function in renal hypertensive
animals might be associated with a decrease in arterial blood pressure
was not confirmed (McCubbin and Page, 1952) and changes of vascular
reactivity were slight in comparison with those of normotensive dogs.
Eleven out of seventeen dogs with Goldblatt hypertension were
found by Wakerlin et al (1957) to have a decrease in systolic blood
pressure when fed diets containing thiouracil and rich in cholesterol.
How much of the fall was due to either of the substances singly was un¬
clear because when given individually neither had an effect on the two
hypertensive dogs on each treatment.
Brull and Op de Beek (unpublished) observed no increase in basal
metobol'ic rate in dogs made hypertensive by the Goldblatt technique.
Brull and Merchie (1958), however, found a progressive increase in
thyroid activity (protein bound iodine) in renal hypertensive dogs.
The PBI was greater later in the course of the experiment than earlier
despite the progressive decrease of blood pressure at the end.

The

technique used in these experiments was unilateral nephrectomy and
clamping of the contralateral renal artery.

How much significance may

be attached to the increased PBI is undetermined since nephrectomy alone
is a stimulus for increased thyroid secretion.
On the basis of the experiments performed on dogs, the thyroid
gland would seem to play no important role in either the maintenance
or genesis of renal hypertension.

This does not mean that there does

not exist a close relationship between the thyroid and experimental
renal hypertension in other animals; and indeed this has been shown
to be true in the rat.

2
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Hypertensive Studies in Eats:

Wastl (1945) studied the influence of two thiourea derivatives
on blood pressure in hypertensive rats.

The substances used caused

a decrease in blood pressure in hypertensive rats but not in normals.
The blood pressure drop occurred during four days of intraperitoneal
injections and returned to preinjection levels within four days.
Although response was said to vary with the dose,

it is puzzling

that the antithyroid effect should have been achieved so rapidly.
Bachtold (1950) found that methyl-thiouracil had no influence
on the blood pressure of normal rats, but that it decreased blood
pressure in renal hypertensive rats only during the course of treatment.
Similarly treatment before hypertension was produced only delayed the
appearance of hypertension.
Thyroxine at a dose of 10 mg per kg per os or 1 mg per kg s.q.
caused a rise in blood pressure in normal animals from 110 to 142 in
two weeks and then a decline to 124 after eight weeks, at which time
treatment was ended.
back to normal.

After thirteen weeks, the blood pressure was

In hypertensive animals, the blood pressure was ele¬

vated from 170 to greater than 230, leading to death.

Thyroxine also

prevented the decrease of blood pressure in hypertensive rats treated
with methyl-thiouracil.
In animals subjected to figure-of-eight ligature of one kidney
and extirpation of the other, given

Vfo saline to drink, thyroidectomy

orthiouracil decreased hypertensive blood pressure levels almost to
normal (Braun-Menendez, 1954).

In rats with moderate reduction in

renal mass, that is ligature alone, thiouracil reduced the slight

V
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hypertension almost to normal.

Thyroid powder (.15-25 mg per day) or

thyroxine (40 pg s.q. per day) increased the blood pressure of normo/
tensive animals with moderate renal mass reduction, and with some
persistence of the increased blood pressure after therapy.
Braun-Menendez and Penhos (1955) found that thyrotropic hormone
raised blood pressure in normotensive or moderately hypertensive rats
with reduced renal mass,

causing a rise to hypertensive levels.

The

effect was not observed in thyroideeternized animals.
Using high doses of tri-iodo-thyronine, Zadunaisky (1957* i960)
showed no increase in the blood pressure of normal rats but an increase
in those rats with reduced renal mass (unilateral nephrectomy, figure”
of-eight ligature and 1 fo saline to drink) during the silent period
before hypertension developed.
by the thyroid gland after

The test of radioactive iodine uptake

2k hours in stable hypertensive and normo¬

tensive control animals showed no appreciable difference.

This would

implicate the thyroid in the developmental period of hypertension.
Osorio (l95o) testing vascular reactivity in normal, hypo- and
hyperthyroid rats found that rats treated with thyroid powder showed
slightly less sensitivity to pressor drugs than normals.
sensitivity of the hypothyroid group was greater.

The decreased

When the hypothryoid

group was treated with vasodepressors they were more sensitive than the
normals.

This latter finding is in agreement with that of Page and

McCubbin (1952) in dogs.
A short communication by Martin and Lehr (1955) reported that
thyroid-parathyroidectomy in rats with renal obstruction delayed the
emergence of hypertension.
Krieger (1956) discovered that thyroid powder (30 mg per day per
os, equal to approximately 117 ug thyroxine*) caused no increase in
4
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"blood pressure in normal rats over a. period of three weeks, whereas
the same treatment in rats with reduced renal mass(figure-of-eight
ligature and unilateral nephrectomy) caused a significant rise in
blood pressure.

2-4 Dinitrophenol had no renotrophic

effect although it shared with thyroxine an

or hypertensive

augmentation of oxygen

consumption.
Recently Fhegly and his colleagues (Fregly, 1958; Fregly and
Hood, 1959; and Iregly, Baker and Gennaro, i960) have explored the
effects of propyl-thiouracil, as well as thyroidectomy, in the
development and maintenance of renal hypertension in rats.

PTU pre¬

vented or removed hypertension associated with bilateral, kidney
encapsulation with latex envelopes; however, the effect was not
permanent.

This treatment also decreased blood pressure in normal

non-encapsulated rats.

The systolic blood pressure of established

hypertensive females was not significantly effected by surgical
thyroid-parathyroidectomy; although this treatment did prevent a
rise in blood pressure to hypertensive levels.

As with PTU, thyroid-

parathyroidectomy reduced blood pressure in normal unoperated controls.
PTU could not decrease further the blood pressure of thyroid-parathyroidectomized rats over a long period of time, although there was
an early transient decrease.
Fregly and Cook (i960) confirmed earlier work that the antithyroid
drugs, thiouracil, propylthiouracil and methimazole, prevented both
the development of increased blood pressure and cardiac hypertroiohy
which usually accompanied kidney encapsulation with latex envelopes.
The drugs also reduced the increased blood pressure in rats with hyper¬
tension of 13 to 40 weeks duration prior to drug administration.
Addition of dessicated. thyroid powder to the diet containing the anti¬
thyroid drug overcame the antihypertensive effect of the latter.
5
*Pharmacopea Aregentina
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Withdrawal of thyroid powder was followed by return of the blood
pressure to previous low levels.

The anti-hypertensive effect of

the antithyroid drugs was attributed to decreased thyroid secretion
rathar. than the extrathyroidal effects of the antithyroid drugs,
decreased food intake, anemia, polydipsia,

eg,

etc.

Thyroid activity as assessed by the ratio of thyroid weight to
body weight, precipitate to serum I
cell height,

131

ratio, and mean thyroid acinar

increased sharply as the systolic blood pressure approached

the high normal or low hypertensive range (Fregly and Gonzales 1961).
The differences shown by dogs and rats may perhaps be explained
by the fact that.although minor degrees of clinical hypothyroidism
can be produced readily in dogs, myxedema is rare.

The dog is unusual

in that it is relatively insensitive to both excess and deficit of
thyroidal hormone.

Brewster et al (195*0 found no significant increase

in mean arterial blood pressure in dogs fed 0.8 grams per kilogram of
thyroid for a period of three weeks,

(compare with Page and Sweet 1937)*

The work that has been done in Europe by Wastl and Bachtold,

in

South America by Braun-Menendez, Penhos, Osorio and Zadunaisky and in
the United States by Fregly would clearly indicate the existance of a
relationship between the genesis of experimental renal hypertension
in rats by the Goldblatt and related techniques and thyroid function.
Decrease in thyroid function does not prevent the occurrence of hyper¬
tension.

The effect of the thyroid on maintenance of established renal

hypertension would seem of less importance.
In addition to the Goldblatt technique, experimental hypertension
has been established by chronic administration of corticosteroids in
large doses or in smaller doses by concomitant administrations of saline

6
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and/or renal injury.

Selye (1950) showed that thyroxine at a dose

of 2 mg per day might be substituted for desoxycorticosterone acetate
in the production of nephrosclerosis and hypertension by a combination
of DOCA,

rp saline as drinking water and unilateral nephrectomy.

The Thyroid in Metacorticoid Hypertension
Selye (1953) determined that thyroidectomy protected considerably
but incompletely against the toxic effects of DOGA.
decreased the power of DOGA to produce hypertension.

In particular it
Thyroxine (Selye

and Bois, 195&) was shown to act as a sensitizing agent in the pro¬
duction of renal and cardiovascular lesions with steroids.
Hypophysectoiny inhibited all the manifestations of DOCA overdosage
(Salgado and Selye, 1953); but the effects of thyroidectomy were nearly
as complete.

Thyroidectomy at the beginning of DOCA treatment (Salgado

and Green, 1956; Salgado, 1953) prevented hypertension, but after the
establishment of DOCA hypertension,

its effect was only short lived.

Thyroid-parathyroidectomy (Salgado and Selye, 195^0 had a dissociative
effect on the cardiovascular and renal changes caused by methyl
androstenediol,

inhibiting the production of hypertension.

The effects

of thiouracil (Salgado, 195^) were found to be similar to thyroidectomy.
The significance of steroid hypertension has been debated because
of the extreme conditions, i.e. the high dose of steroids, necessary to
produce it.

It would be safe to conclude., however, as did Green et al

(1952) and Salgado and Green (1957); that the thyroid might play a
significant role in the development of DOGA hypertension.

Suppression

of thyroid function did not favorably influence established DOCA
hypertension.

7
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Mechanisms of Thyroid Action in Renal hypertension
1)

Vascular Reactivity

2)

Direct Effect:

3)

Indirect Effect:

4)

The Renotropin Hypotnesis

1)

Vascular Reactivity

Kidney Growth and Function
Mediated Through the Adrenals

A frequently discussed possibility is that the thyroid hormone
acts on the calibre of the renal vessels either directly or through
a change of vascular reactivity to various pressor agents.

Sawyer and

Brown (1935) and Aumann et al (1940) found an altered sensitisation of
the adrenergic neuroeffector systems by the thyroid hormone.

They

found no increase in medullary output secondary to hyperthyroidism.
Brewster(195^) discovered that the cardiovascular effects of
thyrotoxicosis were not due to the direct effect of thyroxine per se
but rather to an augmentation of the physiological effects of epineph¬
rine and norepinephrine by thyroxine.

The changes produced by increased

concentrations of thyroid hormone were cfcbolished by preventing the
reflex release of epinephrine and norepinephrine with a total sympa¬
thetic block.

(Brewster et al 1956)•

Roskowski (1956) discovered

that medial necrosis produced by large i.v. injections of epinephrine
was not produced in thyroidectomized animals.
Page and McCabbin (1952) found that vascular responsiveness to
a variety of pressor and depressor drugs in dogs was in some degree

O

o

'

.

dependent on thyroid activity.

Thyroidectomy suppressed vascular

reactivity to a number of substances in normal animals but had little
or no effect in established hypertension.

Osorio (1956) found that rats

treated with thyroid powder showed a little less sensitivity to pressor
drugs when compared with normals and the hypothyroid animals showed
a considerable decrease in sensitivity.

The decrease was quite marked

in hypothyroids treated with depressor substances.
The experiments on vascular reactivity tend to show differences
in vessel reactivity in normal or early hypertensives to that in
established hypertensives.

These results are in agreement with those

which demonstrate a greater and more prolonged reaction of blood
pressure to various treatments in animals which are in the silent
period preceding hypertension or already have mild early hypertension.
2.

Direct Effect:

Kidney Growth and Function

The positive effect of the thyroid on kidney growth is well known
(iscovesco,
1920.

1913> Hoskin, 1910, 1916; Hewitt, 1920; quoted in Cameron

This renotrophic activity was shown by Swann (1939) to be present

in the absence of the pituitary.

Antithyroid drugs were discovered to

produce a decrease in renal weight (Cottet et al, 1951)•
Unilateral nephrectomy caused an increase in thyroid secretion
(Brull and Merchie, 1958); and thyroxine (Dragoni, 1952) increased
compensatory renal hypertrophy in normal rats, although thyroidectomy
did not completely prevent such hypertrophy (Zeckwer et al, 1946).
The thyroid-pituitary axis was proved relatively unimportant since
hypophysectomy did not prevent compensatory renal hypertrophy (BraunMenendez and H.E.J. Houssay, 1959)*

9

.

Ogawa (1958) found a mitosis stimulating factor in the serum of
unilateral nephrectomized rats.

Mandel et al (1953) working on experi¬

mental nephritis showed that thyroxine favored cell repair.
Fateeva (quoted in Brull and Merchie, 1958), using I 0

uptake,

and Brull and Merchie (1958), using FBI, demonstrated an increase in
thyroid secretion to renal ischemia.

Albright et al (l95^)> among

others, had shown that kidney slices could metabolize thyroxine to triiodo-thyronine; and using time reponse tissue studies in thyroxine
injected rats, Barker and Klitguard (1952) found that no tissue was
specifically dependent on another to increase its energy metabolism
turn-over in response to thyroxine.

Since 2, 4-dinitrophenol shared

with thyroxine its actions on oxygen consumption but not on kidney
growth, Krieger (1956) could postulate that the hypertensive effect of
thyroxine was due to its renotrophic action.

Dumont (19^-3) showed that

ischemia of transplanted cervical kidneys pretreated with thyroxine
yielded a greater increase in blood pressure than did ischemia of
transplanted normal kidney.
3.

Indirect Effect:

Mediated Through the Adrenals

Favoring an indirect mechanism for thyroid action in renal
hypertension, Selye (1950,

1953) and Salgado andSelye (195^) proposed

that thyroxine produced kidney lesions and hypertension by means of
an increased production of mineralocorticoids.

Thyroidectomy decreased

adrenalcorticoid production.
Green et al (1952) and Fregly and his co-workers (1958-60) main¬
tained that certain forms of experimental hypertension did not involve

10
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adrenal cortical activity and that propylthiouracil’s effect on blood
pressure was not due to hypofunction of the adrenals.

Fregly was able

to obtain renal hypertension in the face of bilateral adrenalectomy,
confirming earlier work by Fasciolo, 1938.
Several authors (Bauman and Marine, 1945; Deane and Greep, 1947;
Freedman and Gordon, 1950; Farrow and Money, 1949), however, found
that propylthiouracil or thyroidectomy decreased adrenal size.

But

Bosenfield (1952) showed that thyroxine added to artificial perfusate
of calf adrenals gave no
activity.

acute increase or decrease in adrenal cortical

Chappel et al (1958) demonstrated that the weights of adrenals

of PTU treated animals were not significantly less than hypertensives
when expressed in terms of body weight, but a definite histological
difference,

i.e. shrinking of the zona fasciculate was seen.

latter finding confirmed the work of Deane and Greep (1947).

This
Whether

this was an effect of changed ACTH secretion or direct action of
thyroxine is not known.

Martin (1955) wrote of a lack of substantial

adrenal hypertrophy following obstruction nephropathy in thyroidparathyroidectomized dogs.
In a recent work on the thyroid gland in the development and
maintenance of renal hypertension (Fregly and Cook, i960) the increase
in thymus weight ratio which usually accompanied adrenal hypofunction
failed to manifest itself after treatment with antithyroid drugs.
There was also no observed difference with respect to adrenal cholesterol
concentration between encapsulated and non-encapsulated kidneys of
propylthiouracil treated rats.

V
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4)

The Henotropin Hypothesis
Braun-Menendez (1952, 1958) sought to Bring together all work on

experimental renal hypertension hy postulating the existence of a substance
probably connected with intermediary metabolism.

Be suggested that the

kidney existed in a relationship Between certain demands which the Body
might impose and its capacity to respond to them.
adrenals responded to ACTH and the thyroid to T3H.

For example, the
This substance or group

of substances, which has not Been isolated, regulated kidney growth and
function and was named Renotropin.

Its rate of production increased under

the influence of hormones of the anterior pituitary, gonads and thyroid.
Normally there existed an equilibrium Between the production of Renotropin
and its destruction, transformation or utilization By the kidney,

Increase

of Renotropin caused kidney hypertrophy and decrease led to atrophy.

When

the equilibrium was disrupted and the remaining kidney tissue was unable
to respond to the stimulus of normal or increased amounts of Renotropin
present in the Blood, hypertension developed.

The mechanism whereby

hypertension results is unknown, although it may Be through secretion of
renin.
According to the Renotropin Hypothesis any of several hormones and
a high protein diet were capable of interrupting the equilibrium between
Renotropin production and a kidney unable to respond by reason of a
figure-of'-eight ligature, thus causing an increase in blood pressure.
Because most of the body’s hormones and diet exerted an Influence on
blood pressure of renal ischemic origin, Braun-Menendez felt that these
effects were exerted through intermediary metabolism.

--

.

1

Recently Toth and Bartfai (i960), after establishing renal ischemic
hypertension in parabiotic rats, were able to show an antihypertensive
effect in the plasma of the rat with intact kidneys.
Berlant (19-4-9) showed that excess protein or thyroid treatment
caused their greatest hypertrophy in the brush segment of the nephron
where absorption of glucose and other metabolites occurs.

The effect

of the thyroid was secondary to its increasing of substances such as
glucose in the blood stream and its greater reabsorption of such
substances by virtue of its hypertrophic response on the nephron.
Hoffman et al (194-8) showed that adrenalectomy decreased oxygen
consumption in rats by 10$.
oxygen consumption by 20$.

Adrenalectomy and thyroidectomy decreased
The effect of thyroxine on metabolic rate

was decreased in adrenalectomized rats.

Administration of cortical

extract to adrenalectomized rats allowed a normal metabolic response
to thyroxine.

Hoffman et al (194-9 a b ) found that thyroxine injected

adrenalectomized rats did not show the elevation of urinary nitrogen
observed in the controls.

This was also observed in rats adrenal¬

ectomized following thyroid therapy.

If increased urinary nitrogen

was taken as a measure of increased protein metabolism, then the
adrenalectomized rat was incapable of participating in the usual
metabolic acceleration induced by thyroxine.
Handler and Bernhein (l95l) studying the effects of caloric
restriction and the role of the adrenals in renal hypertension showed
a decrease in blood pressure in animals fed a low protein diet and
a restoration of the blood pressure by administration of ACTH or

13
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thyroid powder.
The experiments of Heriant, Hoffman and Handler, although by no
means definitive, would tend to support a unifying hypothesis such as
that of Braun-Menendez in regard to the relationship between interne-”
diary metabolism and renal hypertension.
The experiments reported in this paper were undertaken to further
delineate the interrelationship of the thyroid and adrenal glands in
experimental renal hypertension, especially during the silent period
after the reduction of renal mass and before the appearance of
hypertension.

This is the period when most of the factory concerned

with the production of hypertension would seem to be most active.

14
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Materials and Methods:
white Male rats of the Institute strain were used except for
Experiment 5 where white male histar rats from the Argentine Atomic
Energy Commission were employed.

All animals were kept on the standard

\

chow diet of the Institure.

Tap water was given ad lib; during the

course of the experiments this was changed to

Ufa saline.

In several

experiments the saline consumption during the elapsed period was
measured.
Blood pressure was determined using the plethysmographic technique
of Williams,

Harrison and Grollman (1939 )j>

light ether anesthesia, Fig 1.

slightly modified and using

Each animal’s blood pressure on a

given day was taken as the mean of three consecutive measurements.
Figure-of-eight ligature of the left kidney was performed according
to the technique of Grollman (1944).
usually done one week following.

Contralateral nephrectomy was

Left adrenalectomy was accomplished

simultaneous with the ligature of the left kidney; and right adrenal¬
ectomy, with the right nephrectomy.

In Experiment (6) left adrenal¬

ectomy followed 2 weeks after the ligature of the left kidney and 1
week after the nephrectomy and adrenalectomy.

After each operation and

on the following day prophylactic doses of penicillin were given.
Radio-thyroidectomy was accomplished by the intraperitoneal
injection of 1 mC I
a given experiment.

131

at least 10 weeks prior to the beginning of

This dose is sufficient to produce a complete

destruction of the thyroid gland with sclerosis in 30 days (Goldberg
et al, 1950).

.

.

-

FIGURE 1

4

The sodium salt of thyroxine was dissolved in alkali and demineral¬
ized water and frozen in aliquots sufficient for daily 0.2 ml. s.q.
injection for each experiment.
Hydrocortisone was weighed out in daily aliquots and,

on the

day of use, dissolved in methyl alcohol and water for 0.2 ml. s.q.
injections.

Hydrocortisone had been shown (Thiedman et al, 1952, 1953)

to have a smaller hypertensive effect than DOGA, and also not to be
potentiated by 1$ saline to drink and unilateral nephrectomy.
Upon death, the animals were examined grossly for kidney abscess,
lung lesions, periarteritis and thyroid remanents.
At termination of each experiment, except experiment (3), autopsies
were performed, and the weight of the organs were d_etermined within five
minutes of sacrifice.

The organs were carefully

blotted before weighing.

trimmed and gently

Values were expressed, as a percentage of

body weight.
Representative tissues were taken from several experiments and
submitted for microscopic inspection.

16
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Summary of Experiments

.Thyroxine
Normals v
"Saline

(Expt. l)

»
Thyroxine
Ligature in 8 plus
Nephrectomy

/

Same with sustain¬
ing dose hydrocort¬
isone, (Expt. 4,5)

(Eixpt.2)

\ Saline

Thyroxine
Ligature in 8 plus '
Nephrectomy and
\
Adrenalectomy
v
Saline

(Expt.2)

Thyroxine

/
Ligature in 8 plus
Nephrectomy and
Adrenalectomy and
Thyroide ctomy
\

Same with sustain¬
ing dose hydrocortisone,(Expt. 6)

(Expt.3)

Saline

M
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EXPERIMENT

1

Preliminary experiments, using dose levels of 25 ug and 100 ug
respectively, in animals -with reduced renal mass (figure-of-eight
ligature of one kidney and contralateral nephrectomy) given Vfo saline
to drink, had, in the first case (25 ug) shown little rise in hlood
pressure and, in the second case (100 ug) had resulted in the early
death of most of the rats.

Thyroxine at 50 ug (s.q. over 7 day or

longer periods) given to experimentally prepared animals resulted in
a satisfactory rise in "blood pressure and relatively low mortality
rate.
In Experiment 1, the effect of thyroxine at 50 ug dosage on
normal animals was tested.

Earlier investigators (Bachtold, 1950

and Krieger, 195&) had shown that thyroxine at 100-150 ug/day for
more than two weeks and thyroxine at 117 ug/day for 21 days in
normal animals caused a non-sustained rise in blood pressure.

Did

the 50 ug dose of thyroxine in experimentally prepared animals merely
increase an effect which might be shown in normal animals?
Eight male rats of the Institute strain weighing between 103 and
151 grams were placed 2 per cage and given 1$ saline and regular diet
ad lib.

For 7 out of the following 10 days, normal or basal blood

pressure determinations were made.

On day 10, 5 of the rats were

begun on thyroxine, 50 ug on 0.2 cc s.q. and the remaining 3 rats

1

on O.O85

°

saline.

Injections were carried out for 8 days and blood

pressure was determined on days 11, 14, 16 and 17.

On the day

following the last injection (day 9) after the blood pressures were
read, 3 animals of the thyroxine treated group and 3 from the saline

- O
•

CJ

.

.

.

.

control group were sacrificed and kidney and heart weights determined.
Body weights were measured at the beginning of the experiment,
the first day of injections,and at autopsy.

on

Blood pressure determinations

(Fig.2) are represented as averages of 2 days or 6 reading i.e. three
individual readings per day x 2.
RESULTS:
TABLE 1:

NORMALS (EFFECT OF 8 DAYS OF THYROXINE TREATMENT AT 50 ug
Kidney
(mg/o BW+ SD)

Heart
(mg^b BN + 3D)

Body Weight
(cp change)

Saline Control

.523 + .014

.448 i .011

+9.15 + 0.21

Thyroxine

.554 + .027

.446 + .042

+2.19 ± 7.65

P > .6

p > .1

P >

-3

There were no significant differences in blood pressures, weight change
or kidney and heart weight between the thyroxine and the saline treated
group.
Although the small number of animals precludes a strong statement,
it appears the 50 ug dose of thyroxine over an 8 day period does not
result in a significant change in the blood pressure of normal animals,
nor in heart or kidney weight.
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EXPERIMENT 2
In an earlier work (Braun-Menendez, 1953) it was shown that the
treatment of normotensive rats with moderate renal reduction (i.e.
figure-of-eight ligature of one kidney, 4 to 5 months prior to therapy)
with thyroxine (40 ug x 7 days) provoked a definite and in some cases
sustained rise in blood pressure.

In 3 normotensive rats, which had

undergone figure-of-eight ligature of one kidney and contralateral
nephrectomy 4-5 months previously, treatment with thyroid powder
(15-25 mg qd x 10*l8) resulted in an increase in blood pressure.
Although in the above animals there was no increase in blood
pressure following the operations 4 to 5 months prior,

there remains

the question of changes having occurred inthe period before the be¬
ginning of thyroxine treatment which might have effected the results
obtained, e.g.

changes in kidney weight.

Many workers have shown that

once hypertension and/or its underlying vessel pathology have become
established the effects of thyroxine therapy are changed.
In the following experiment, an effort was made to determine
1) the effects of thyroid administration on prepared animals,

i.e.

figure-of-eight ligature of one kidney and contralateral nephrectomy,
during the latent period prior to the appeaj^ance of hypertension and
2)

the effects of adrenalectomy on the above treatment.

The latter

would possibly indicate whether the effects of thyroxine were directly
upon kidney growth and function or indirect,!, e. -mediated through the
adrenals.
The dosage used (50 jig) gave no increase in blood pressure in
normal animals (Experiment l).
Materials and Methods

58 white male rats of the Institute strain between 108 and 206 grams

-

-

-
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(all but 5 between l40 and 206 grams) were divided into 5 groups.
Four groups had figure-of-eight ligature of the left kidney followed
one week later by right nephrectomy.
adrenalectomized.

Two of the four groups were

Unilateral adrenalectomy ms performed with each

operation on the respective kidney.

The fifth group contained normal

controls.
Number of
Treatment
Group I

Bats
Ligature Left Kidney, Right Nephrectomy

Group II

"

"

11

Group III

n

"

"

Group IV

n

"

Group V

"

"

"

Saline controls

8

Thyroxine 50 ug

14

,Adrenal~x Saline controls 11
"

"

Normal Controls

k*

Thyroxine 50 ug

20

Saline

5

The rats were placed 2 per cage and given the regular Institute
diet, and 1$ saline ad lib.
per 100 grams body weight.

The latter was measured as ml. consumed
Injections were begun on the day following

the last operation and lasted for 7 days.

Autopsies were performed on

the surviving animals four days after the final injections.
pressure was determined on the 2nd, 4th,
the injections were begun.

Survival
Group I
Group II

8/8
ll/l4

Group III

7/H

Group IV

6/20

Group V

5/5

6th,, 8th and 10th days after

Blood pressure for the normal saline controls

were taken on days 4, 8 and 10.
RESULTS

Blood
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Blood Pressure

In Both groups treated with thyroxine, the mean

blood pressure was greater than the mean blood pressure of the saline
groups.

The significance of the blood pressure curves was determined

by comparing three points in each group: day 2; the mean of days 4 and
6; and the mean of days 8 and 10.

In comparing groups I and II, only

the last point on the graph was significantly different (p less than
.02 and .01) (Figure 3)*

In the nonaarenalectomized groups ( I & II)

or groups with reduced renal mass only, both the saline and thyroxine
treated groups had higher mean blood pressures than the normal controls;
however in the two points compared, only the thyroxine treated group
was significantly different ( p less than .01, less than .05).(Figure 4)
In the adrenalectomized groups with reduced renal mass i.e. Ill and IV,
the mean pressure of the normal rats fell between the saline and
thyroxine treated groups but only the final point of the saline group
was significantly lower.

The thyroxine group mean blood pressure was

not significantly higher. (Figure 4)
Water Consumption:
Water consumption between Group I and II was not significantly different.
This also applied to Groups III and IV.

However the mean of the saline

consumption per 100 grams body weight of the two adrenalectomized groups,
i.e. Ill and IV was lower than the group with reduced renal mass alone.
Autopsy:

Table 2

Adrenals:

The thyroxine treated group II was significantly higher

than the normals (V), p less, than .02.

The saline group (l) was

higher but not significantly so.
Kidneys:

Both thyroxine treated groups II and IV were significantly

heavier than their respective saline controls (Groups I and III)
(p less than .02 and .05 respectively).

When compared to the
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EXPERIMENT 2

TABLE 2

Adrenal:
mgio

Thyroid

.336+.038

.00210+.00045

.OO85+.0012

.867+.136

.403+.045

.00295+.00086

.0099+.0030

-1.7 +5-0

,718+.082

.308+.018

«

.0099+.0021

+ Thyroxine -13.331,6.1

.890+.124

.3551*056

.419+.044

.289+.014

Group

Weight
ia Change

Kidney

+9•30+6•6

.706+.050

+2.45+7•2

mgj>

Heart
mgio

mg°!o

I RRM* +
Saline

II RRM +
Thyroxine

III RRM + Adrenal-x
+ Saline

IV RRM + Adrenal-x

V Intact Controls
+ Saline
+9 * 1+2.2

.0086+.0018

.00168+.00026

.0110+.0020

* RRM = Reduced Renal Mass (Figure-of-eight ligature of one kidney and
contralateral nephrectomy)
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normal controls; all four graaps were significantly different (p less
than .01 in all cases).

Within the saline treated groups (I and III)

adrenalectomy caused no significant change.

There was also no significant

change in the thyroxine treated groups (II & IV)
THYROID:

Adrenalectomized thyroxine treated group IV was significantly

lighter than its respective saline control(lll) p <.01; but the nonadrenalectomized thyroxine treated Group II was significantly heavier
than its saline control I, p< .01.

All groups -with the exception of

non-adrenalectomized thyroxine treated Group II were significantly
lighter than the normal controls.

The saline treated groups I and

II and the thyroxine treated groups II and TV were not significantly
different within their groups.
HEART:

Of the thyroxine treated groups only that with reduced renal

mass without adrenalectomy (ll) was significantly higher than its
operated control ( p< .05).

When compared to the normal saline

controls; all groups with the exception of Group III (reduced renal
mass with adrenalectomy plus saline treatment) were significantly
different.

The saline groups and the thyroxine groups were not sig¬

nificantly different among themselves.
WEIGHT:

Both adrenalectomized groups lost weight and both non-

adrenalectomized groups gained weight.

Both thyroxine treated

groups weighed less than their saline controls.

With the slight

exception of the saline treated non-adrenal-x animals;

1, the

other groups weighed less than the normal saline controls.
Experiment II demonstrates that in both adrenalectomized and non
adrenal-x animals with reduced renal mass (i.e. figure-of-eight ligature
and contralateral nephrectomy)

thyroxine at a dose ineffective in

normal animals is capable of raising blood pressure.
however; decreased the extent of the rise.

Adrenalectomy;
24
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Whereas thyroid treatment in hoth adrenalectomized and nonadrenalectomized rats caused increases in kidney weight both above
respective saline and normal controls, there was no significant
difference between the two thyroxine treated groups: this was also
true for the saline controls.

Only the hearts of the non-adrenal-

ectomized thyroxine treated group were significantly increased above
their saline controls.

The adrenalectomized thyroxine treated rats

and their saline controls showed no significant difference.

There was

no significant difference between the two thyroxine treated groups;
this also held true for the saline treated groups.
Thyroxine treatment significantly decreased the weight of the
the
thyroids (below their saline controls) in/adrenalectomized group;
but in the non-adrenalectomized group, the thyroxine treatment increased
thyroid weight above their saline controls.
There was again no Ir¬
respective
ference between the/thyroxine treated groups; nor between the respective
saline groups.
Thyroxine increased the weight of the adrenals significantly over
the normals but not over the saline controls.

Within the adrenalect¬

omized and non-adrenalectomized groups treated with thyroxine, although
no significant differences existed, the kidney responded less in the
non-adrenalectomized group and the heart less in the adrenalectomized
group.

Adrenalectomized animals, both thyroxine and saline treated,

consumed less saline; however within both saline and thyroxine treated
groups of the adrenalectomized and non-adrenalectomized subdivisions
there were no significant differences.
Further experiments will be necessary to assess the autopsy findings;
however it seems that thyroxine is capable of reacting without the
adrenals to raise blood pressure.
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EXPERIMENT

This experiment repeats the preceding experiment (2) hut employs
thyroidectomized. as well as adrenalectomized animals to eliminate
possible influences of endogenous thyroid secretion.

In the preceding

experiment the thyroid glands in non-adrenalectomized animals with
reduced renal mass were significantly increased over the saline controls
with reduced renal mass following seven
Materials and Methods:

days of thyroxine treatment.

Twenty-two white male rats of the Institute

strain, weighing between l46 and 201 grams, except for two weighing
127 and 2l6, were thyroidectomized with intraperintoneal injection of
1 mC I

131

, seven weeks prior to the beginning of the experiment for the

thyroxine group and 10 weeks prior to the onset for the saline group.
The thyroxine treated group consisted of 10 animals.

Figure-of-eight

ligature of the right kidney and right adrenalectomy was followed nine
days later by nephrectomy and left adrenalectomy.

Injections of 50 jug/day

thyroxine were begun on the day following the last operation and continued
for seven days.

The experiment was terminated two days after the final

injections(nine days after the beginning of the experiment).

The saline

group consisted of 12 animals with the above operations and lasted the
same time.

Blood pressures were determined almost daily, except for

day three in the thyroxine group and day four in the saline group.
Autopsies were not performed and the animals were allowed to continue
with periodic blood pressure determinations until death.
Results:

Survival (to ninth day)
Thyroxine Group 5/l0 (l animal survived ih days after
adrenale ctomy)
Saline Group 6/12 (l animal survived l4 days after adrenalectomy)

-

-

..

Blood Pressure: (Figure 5)

The thyroxine group blood pressure

increased above its base during treatment and the saline group
decreased below its pre-experimental levels during treatment.
curves (Figure 5) represent average of two days readings.
two points on the graph are significantly different ( p

The

The last
less than .01)

and the third from the end, not significant at p greater than .05.
Weight Change:

Weights declined but were not significantly different.

The thyroxine treated group lost 12.1+ 13*8 per cent and the saline
group lost 13*7 i. 15*0 per cent.
It appears in this experiment that thyroxine maintained but did
not increase significantly the blood pressure of both thyroidectomized
and adrenalectomized rats with reduced renal mass.
The mortality in both Experiments 2 and 3 reflects the delicate
state of the animals.

For this reason, a sustaining dose/was added

and both experiments were repeated as follows.
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EXPERIMENT 4
This experiment repeats Experiment 2 using sustaining doses of
hydrocortisone to attempt to improve survival rates and to bring the
animals to a better state of physiologic balance than they were without
any endogenous steroid.

Friedman et al

(1952, 1953) had demonstrated

that hydrocortisone in uninephrectomized rats at .05 mg did not cause
steroid hypertension nor was its action potentiated by 1$ saline
as drinking, water.
Materials and Methods
Twenty-four white male rats of the Institute strain weighing
between 127 and 188 grams were divided into two groups.

In one,

ligature of the left kidney and left adrenalectomy was followed one
week later by right nephrectomy and adrenalectomy.

The other group

was operated upon at the same time but adrenalectomies were not per¬
formed.

All rats were given 0.25 mg hydrocortisone on the day of the

second operation and 0.5 mg thereafter.

Both groups were subdivided

into saline controls and thyroxine treated animals.
groups received 50

The thyroxine

thyroxine daily beginning the day after the

last operation and lasting for fourteen days.

The hydrocortisone was

continued for two days beyond and the survivors were sacrificed on
the next day or seventeen days after adrenalectomy.
Blood pressures were determined on days 3> 4,5j> 7_>9jH>14 and l6
after the second operation.

The animals were given 1$ saline ad lib.

Results:
Survival (After Seventeen Days)
Group I " Reduced Renal Mass, Adrenalectomy - Saline 5/8

,

.

.

■

x

Group II ™ Reduced Renal Mass, Adrenalectomy -■ Thyroxine

4/9

Group III- Reduced Renal Mass

- Saline

2/3

Group IV - Reduced Renal Mass

- Thyroxine 4/4

Blood Pressure:

In the non-adrenalectomized group there was no difference

Between the thyroxine group and saline controls.

In the adrenalectomized

group, the mean thyroxine hlood pressure was higher than the saline
control, only the last point on the curve showed a significant difference
f

(p < .05) - however Blood pressures of Both groups fell during the course
of the experiment.
Autopsy:

(Table 3)

Kidney:

In Both adrenalectomized and nonadrenalectomized groups,

thyroxine treated kidneys were heavier than their saline controls. But
only significantly so ( p<.Ol) in the adrenalectomized group.

The

Body weight of the nonadrenalectomized thyroxine treated group was
significantly heavier than-the saline injected adrenalectomized group
( P < .02) .
Heart:

The saline treated adrenalectomized group I was signi¬

ficantly lighter than all other groups.
Thyroid•

The mean thyroid weights in the thyroxine treated Groups

II and IV were lower than their respective saline controls, But not
significantly so.

There was also no significant difference Between

the thyroxine treated groups themselves (II vs. IV) or the saline
controls (l vs. III).
Adrenals:

The thyroxine treated group mean adrenal weight was

higher than the saline controls but not significantly so. ( p> .3)
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EXPERIMENT 4

TABLE 3

Group and No.

I RRM*,
adrenal-x
+ Saline (5)

Weight
$ Change

+2.85*7.1

II RRM,
adrenal-x
+ Thyroxine (4) +1.4*11.8
III RRM
+ Saline (2)

+0.13*12.24

Kidney
mg i

Heart
mg %

.740*.062

.332*.052

.0138*.0022

.881*.033

.444*.063

.0119*.0019

.778*.103

Adrenal
mg %

.454*.015

.00218*

Thyroid
mg io

.0131*.0015

.00022
IV RRM
+ Thyroxine (4) +2.36=fcl4.5

.849*.057

.449*.078

,00252*

.0127*.0030

* RRM = Reduced Renal Mass (Figure-of-eight ligature of one kidney and
/
contralateral nephrectomy)

3°

:

-

Weight:

All groups gained weight hut exhibited no significant

differences when compared.
The poor results obtained in Experiment IV as opposed to Experiment
II with regard to blood pressures correlate with the poor differences
exhibited by the kidney and other organs at autopsy.

This experiment

is repeated in Experiment V using a different strain of animals and
extending the experiment over a longer period of time.

ojl

. I'

EXPERIMENT 5
Earlier work by Lascano-Gonzalez (193^) on rats of the Institute
strain had demonstrated the appearance of accessory adrenal glands in those
rats which survived bilateral adrenalectomy. The maximum adrenal insuf¬
ficiency occurred five to fifteen days post-operatively. It was with the
intent of avoiding adrenal secretions from the accessory glands that all
experiments reported - except this one which was carried out on a different
strain - were never carried beyond two to three weeks. However;, it was
reported that the Wistar rats of the Argentine Atomic Energy Commission
strain did not exhibit any significant accessory adrenal growth post
adrenalectomy. This allowed the carrying out of a more prolonged experiment
with adrenalectomized rats on sustaining doses of hydrocortisone which
would repeat with a greater chance of success the previous experiment (4).
Materials and Methods:
Eighteen male Wistar rats weighing between 147 and 167 grams were
divided into two groups. Group I consisted of eight operated saline controls
and Group II, of 10 operated thyroxine treated experimentals. Ligature of
the left kidney and simultaneous left adrenalectomy was followed one week
later by combined right adrenalectomy and nephrectomy. On the day prior to
the second operations, Groups I and II were begun on 0.5 mg hydrocortisone
s.0.; this dose was continued until the twelfth day after the second
operation whenit was decreased to 0.25 mg* this later dose continuing
daily until the end of the experiment. On Day One following the second
operation, Group II was begun on 10 ug thyroxine s.q.; on Day Thirteen,
this was increased to 25 ug; and on Day Twenty-five, this was again
increased to 50 ug, this last dose continuing for eight days -until the
end of the experiment. The hydrocortisone at 0.25 mg was continued for
two days beyond the termination of thyroxine therapy.

On the Thirty-fourth

day after the second operation, the animals were sacrificed.
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All animals were kept in individual cages and given ad lib food
and 1$ saline. The blood pressures of Groups I and II were measured every
second day. Autopsies were performed in the usual manner using the
Roller-Smith Balance. Four normal untreated animals with pressure in the
normal range were also sacrificed.
Results:
Survival: All animals, except one in the Saline treated Group I,
survived.
Blood Pressure:

(Figure 6) Determinations are represented as the

average of the mean o f two successive days' readings. Approximately midway
in the course of the treatment with the dose level of 10 ug thyroxine, the
thyroxine Group II had a higher mean blood pressure than the Saline control.
This difference was maintained until the end of the experiment; however,
only the last two points on the graph were significantly different
(p <.01 and p < .05).
Weights: Both Groups I and II gained weight. Group I, +50.1*6.1
per cent and Group II, 37.8*2,4 per cent. This represented a statistically
significant difference of p < ..05 in favor of the saline controls.
Autopsy:
Kidneys: Both operated Groups I and II were significantly
(p < .01) heavier than the normals; and the thyroxine treated Group II was
significantly heavier

(p <.0l) than its saline control Group I.

Heart: The thyroxine treated Group II was significantly heavier
than both its saline control Group I ( p<.ol) and the normal controls.

(p< .01)

The saline control Group I, however, was not significantly heavier than the
normal controls ( p<.05).
Thyroid: The only significant difference existed between the thyrox¬
ine treated Group II which was lighter (p <.01) than the normal control.
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EXPERIMENT

5

Group and No.
Intact
Controls (4)

TABLE

4

Weight
$ Change
—

Kidney
mg<f>

Heart
mg$>

Thyroid
mg$

.4l4*.005

•3025±.oi4

.0120*.0004

RRM, Adrenal-x
Saline (7)

+50.1*6.1

,685*.024

•348±.Ol6

.0106*.0008

RRM*, Adrenal-x
Thyroxine (lO)

+37.8*2.4

.820*.018

.413*.031

.0083*.ooo4

*KRM (Reduced Renal Mass = Figure-of-eight ligature
of one kidney and contralateral nephrectomy)
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Experiment 5 again exhibits the ability of thyroxine to increase
blood pressure in adrenalectomized rats with reduced renal mass.
With sustaining doses of hydrocortisone, the saline group maintained an
almost normal blood pressure level.

This gives more significance

to the rise in blood pressure of the thyroxine treated group.

.

EXPERIMENT 6

This experiment repeats the earlier Experiment (3) using sustaining
doses of hydrocortisone in thyroidectomized and a.drenalectomized rats
with reduced renal mass.
Materials and Methods
Ten white male rats of the Institute strain, weighing between 136
131
and 165 grams., which bad been given 1 mC I '
nine weeks prior to the onset
of the experiment were subjected to the following operations:

l) Figure-

of-eight ligature of the left kidney, followed seven to,nine days later by
2) Right Adrenalectomy and Right Nephrectomy, followed four to six days
later by 3) Left Adrenalectomy.
The animals were divided into two groups: Group I: Five animals
received hydrocortisone and saline, and Group II: Five animals received
thyroxine and hydrocortisone. One mg hydrocortisone was given on the day
of the last operation in divided doses and a sustaining 0.5 mg divided
daily dose thereafter.

Saline and thyroxine (50 ug) injections were begun

on the day following the last operation and continued for twelve days.
The hydrocortisone was continued two days beyond that.
Animals were kept in separate cages and given normal chow and 1’jo
saline to drink. Autopsies were performed on the day following the last
hydrocortisone injection or sixteen days after complete adrenalectomy.
Blood pressures were determined each second day after the last operation.
Kidneys and hearts were weighed and the thyroid region inspected grossly.
Results
Survival:
Group I: RRM, Adrenal-x, Thyroid-x

+ Saline

3/5

Group II:RRM, Adrenal-x, Thyroid-x

+ Thyroxine

k/
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EXPERIMRTW 6

TABT.F 5.

Adrenalectomized, Thyroidectomized Rats with
Reduced Renal Mass

Weight
^Change

Kidney
mgio

Heart
mg^

Group I Saline +
Hydrocort.(4)

-3.3*8.4

.611*.033

.371*.o4i

Group II
Thyroxine +
Hydrocort.(3)

-4.4±1.8

.739*-084

.393*.027

Group and No.

Results (cont.)
All animals shoved no evidence of thyroid tissue grossly.
Blood Pressure:

(Figure 7) The thyroxine treated group shoved, an

increase in blood pressure over the saline treated group. The last tvo
points on the graph vere significantly different, p<.05 and p<.ol,
respectively.
Body Weight: Both groups lost veight. Group II (Thyroxine) -4.4±1.8
per cent and Group I )(Saline) -j3.3*8.4. These differences vere not
significant.
Autopsy: The Kidneys in the thyroxine treated, group vere significantly
heavier (p<.05) than the saline group.

The Hearts in the thyroxine

treated group vere also heavier than the saline treated group but not
significantly so.

It has again been demonstrated, that thyroxine can increase above
normal the blood pressure of adrenalectomized rats. This continues to cor¬
relate veil vith the increase in kidney veight and less veil vith the increase
in heart veight.

A compilation of many determinations of blood pressure shoved the
distribution curve of thyroidectomized animals to be lover than that of
normal animals. The curve for the normal animals gives good agreement
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■with blood pressure obtained in normal rats by other authors.
(Figure 8).
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RESULTS:
It has been demonstrated that thyroxine treated rats with figureof-eight ligature of one kidney and unilateral nephrectomy, which have
been adrenalectomised or both adrenalectomized and thyroideatomized,
show a restoration of blood pressure to above normal or slightly
hypertensive levels*
normal animals.

This occurred at a dose level ineffective In

This also occurred during the lag phase prior to the

time of the usual appearance of experimental renal hypertension.

The

effect on blood pressure of thyroxine was augmented by supplying sustaining doses of hydrocortisone.

In experiment

administration were amply demonstrated.

epects
the longer term/of thyroxine

These results were enhanced when

compared to the saline controls because of the decrease, quite large in
several instances, of blood pressure below normal levels.
Treatment of adrenalectomized rats with thyroxine increased the
mortality, as had previously been shown (Zwemer, 1927; Hoffman et al,
1948),

This was also true of adrenalectomized-thyroidectomized rats

treated with thyroxine.

Sustaining doses of hydrocortisone given

to such animals, however, decreased the large mortality,

confirming

Koelsche and Kendall (3,935).
In Experiments 2 and 4,adrenalectomy did not cause any significant
difference in the effects produced by thyroxine on kidney, heart and
thyroid weight.

With the exception of Experiment 4,

thyroxine caused

a significant increase in kidney weight over both saline and normal
controls in the adrenalectomized and also in the nonadrenalectomized
groups.

This was well correlated with the effect on blood pressure.

The effect of thyroxine on heart weight was less striking (Tables 4^5).
The weight of the adrenal glands was increased (Experiments 2 and 4),
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but the difference was not significantly greater than the saline
controls.

This is in agreement with Pekkarinen. et al, 1951 j Preston

1928; and Ingle and Higgins, 1938.
Except for the adrenalectomized rats in Experiments 2 and 4,
thyroxine caused the non-adrenalectomized rats to gain less weight
than their saline controls; and all adrenalectomized thyroxine treated
rats to lose more weight than their saline controls.
As for 1 c/o saline drinking water, thyroxine made no significant
difference between saline or thyroxine treated groups, whether these
animals were adrenalectomized or not.
Microscopic examination of tissues taken from autopsied animals
failed to show any significant histopathological difference between
experimental animals and controls.
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DISCUSSION:
That thyroxine has a hypertensive effect on animals with reduced
renal mass has been confirmed.

That thyroxine has a definite if not

marked effect on adrenalectomized animls with reduced renal mass has
also been demonstrated.

The effect on blood pressure in the absence

of adrenals is quantitively less; however, the renotrophic effect is
statistically undiminished.

Accepting the role of the kidney in

experimental renal hypertension,

one finds that

the adrenals are

qualitatively unnecessary for renal hypertrophy; and hence their effect
on increased blood pressure is quantitative or "permissive'1.
If the adrenal’s role is minimized, it is interesting to investi¬
gate other possible factors in the mechanism of thyroid action.
Brewster (195*0 and Page and McCubbin (1952) showed a correlation
between thyroid activity and the sensitivity of the heart and blood
vessels of dogs to infusions of catecholamines.
in rats by Osorio (1956)*

The same was demonstrated

The effect of such changes in vascular re¬

activity or increased secretion of catecholamines seems of minor rather
than major importance here.

In Experiment 1, a 50 jig dose of thyroxine

given to normal animals had no measureable effect on blood pressure.
In Experiment 5 which lasted over a month, it would be hard to concede
a major role to a continuing change in vascular reactivity (without
histologic change) or increased secretion of catecholamines,
especially in adrenalectomized animals.

Other investigators (Alpert,

1937; Pickering, 1955; Von Euler, 1956) have found no change in levels
of catecholamines in experimental renal hypertension.
Thyroxine’s effect in increasing heart weight is well known.
Sandler and Wilson (1959) studying the production of cardiac hypertrophy
by thyroxine in the rat found that increased heart weight was due to
muscle hypertrophy and not to changes in water or electrolytes.

The

response of the heart was secondary to an increased metabolic rate and
4l
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and hence demand for oxygen (Rasmussen, 1941).

Krieger(l956) found

that dinitrophenol increased oxygen consumption; however, it was only
thyroxine that increased blood pressure.
Fregly and Gonzales (1961) found that oxygen consumption in renal
hypertensive rats did not have a close relationship to systolic blood
pressure.

These authors asked whether the thyroid weight ratio increased

in response to a rising systolic blood pressure or to an increasing
heart weight ratio.

In our experiments, studying the lag period before

the appearance of hypertension, the thyroxine injections were effective
in the absence of both prior increase in blood pressure and cardiomegaly.
There is no doubt that adrenalectomy decreased the vitality of
our experimental animals, and hence lessened the effect of thyroxine
or rather increased mortality to these injections.
of hydrocortisone, however,

Sustaining doses

improved the experimental conditions and

hence the ability of thyroxine to enhance renal hypertension in the
absence of adrenal glands.
Further study of the role of the thyroid in experimental renal
hypertension are indicated.

Over a period one might study I

131

uptake;

the changes in content of thyroid hormones in the gland and plasma;
the histology of the thyroid during the course of development of renal
hypertension; and respiration in various organs and tissues during the
phases of hypertension, thyroid hyperfunction and adrenal insufficiency.
Very little is known about the early stages in experimental renal
hypertension.

As in humans, once hypertension becomes established the

factors that may have given rise to it diminish, in importance.

Green et al
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(1952) demonstrated the un-importance of both the adrenal and the
thyroid in post DCA hypertension.

In humans, thyroidectomy (Kountz

and Humpelmann, 19^0) and antithyroid drugs (Beamish and Adamson,
19^5) failed to lessen established, hypertension.

The future seems

to lie more clearly with the prevention rather than the treatment
of the disease.

And. it is to that end that studies of the many

factors giving rise to hypertension are important.
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RESUMEN

Ha sido demostrado que en ratas con ligadura en ocho de un rinon
y nefrectomia contralateral y que han sido adrenalectoraizadas o adrenal¬
ectomizadas y tiroidectomizadas; el tratamiento con tiroxina les determina
un restablecimiento de la presion arterial, en niveles por encima de lo
normal o discretamente hipertensivos. Este efecto se observe, durante la
fase previa a la aparicion de hipertension con dosis que no producen
modificaciones en animales normales. El efecto de la tiroxina sobre la
presion arterial fue potenciado por la hidrocortisona en las dosis
habituales de mantenimiento.
El tratamiento con tiroxina determino una mortalidad aumentada en las
ratas adrenalectomizadas o adrenalectomizadas y tiroidectomizads,s; las
dosis de mantenimiento de hidrocortisona disminuyeron el grado de mortalidad.
El efecto de la tiroxina sobre el peso del rinon , del corazon
y de la tiroides no fue modificado significativamente por la adrenalectomia.
El efecto de la tiroxina sobre la presion arterial tuvo una buena
correlacion con el grado de hipertrofia renal conseguido con el tratamiento.
Han sido discutidos los posibles mecanismos de accion del efecto
encontrado, presentandose tambien un resumen de la literatura sobre el
papel de la tiroides en la hipertension renal experimental.
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